Warner Chilcott, manufacturer of estrogen-replacement therapies and acne drugs, confirmed it has been approached by one of three financial outfits with apparent plans to buy the company, but would not identify the suitor. Since three are said to be interested, the idea of an auction for the company was developing, and a source said Goldman Sachs Capital Partners is the group that made the approach.

Related Summaries